Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?

Chairpersons: V. Bapat, S. Windecker

Panellists: V. Falk, J. Mehilli, N. Van Mieghem, C. Young

Summary

Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex coronary disease.

Learning Objectives

To understand how to translate the outcome of clinical trials into your day-to-day clinical practice
To learn how individual patients fared after randomisation in the pivotal low-risk trials
To translate clinical trial outcomes into real-world decisions by your Heart Team

Presentations available when logged in:

Session objectives
Case 1: a 70 year-old patient with severe aortic stenosis and a bicuspid aortic valve
Case 2: a 65 year-old patient with severe aortic stenosis and a small annulus
Case 3: a 70 year-old patient with severe aortic stenosis and complex coronary disease

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?

Learning Objectives

Log in or create account for free